Neuraminidase inhibitors sensitivity in Cambodian H5N1 and H1N1 pandemic influenza viruses
2011

Sensitivity of Influenza Viruses to Neuraminidase Inhibitors in Cambodia

publication

Author Information

Author(s): M. Naughtin, S. Mardy, S. San, J.C. Dyason, M. von Itztein, P. Buchy

Primary Institution: Institut Pasteur in Cambodia

Hypothesis

The study aimed to monitor drug resistance in H5N1 and H1N1 pandemic influenza viruses in Cambodia.

Conclusion

The study found no evidence of NAI drug resistance in H1N1pdm viruses, but identified mutations in H5N1 viruses that reduce sensitivity to NAIs.

Supporting Evidence

  • We analyzed the genome of H5N1 strains isolated from poultry and humans in Cambodia between 2004-2010.
  • We identified a small number of H5N1 outliers with reduced susceptibility to neuraminidase inhibitors.
  • We found no evidence of NAI drug resistance in H1N1pdm viruses in Cambodia.

Takeaway

Researchers checked if certain flu viruses in Cambodia were resistant to medicine and found that while one type was not resistant, another type had some changes that made it less sensitive to the medicine.

Methodology

A chemiluminescence-based in vitro assay was used to determine the concentration of drug required to inhibit 50% of neuraminidase enzyme activity.

Digital Object Identifier (DOI)

10.1186/1753-6561-5-S1-P68

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication